Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin dose-finding in women with BMI ≥ 40kg/m2
NCT03672045Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Nov 2018
- Primary completion
- May 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of carbetocin in postpartum hemorrhage (PPH) (6 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Intraoperative requirement for additional uterotonic medication at 1 hour. Started Nov 2018; status: completed.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03672045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03672045.